Why Do We Use Hypocapnia in Patients After Acute Brain Injury?
The Monro-Kellie doctrine states that the total volume of the intracranial contents must remain constant because the cranial cavity represents a fixed volume. An increase in the volume of any intracranial compartment (e.g., cerebral edema, hematoma, or brain tumor) can initially be compensated by displacement from another compartment. However, when intracranial content volume exceeds a threshold, ICP increases precipitously ( Fig. 1 ). Intracranial hypertension (sustained ICP Ͼ20 mm Hg) may cause secondary brain injury by impairing cerebral perfusion, direct pressure, or by brainstem herniation.
Hypocapnia is induced to lower ICP by decreasing the cerebral blood volume (CBV) via cerebral arterial vasoconstriction (Fig. 1) . The effects are potent: cerebral blood flow (CBF) decreases by approximately 3% per mm Hg change in Paco 2 (range, 60 to 20 mm Hg PCO 2 ) in patients with traumatic brain injury (TBI) (9).
(12)-that recommend limitation of hypocapnia to intracranial hypertension accompanied by neurologic deterioration.
Hypocapnia in Adults. The Brain IT initiative, a collaboration of 38 European centers that provide care for braininjured patients, has established a TBI database from which Neumann et al (10) recently analyzed arterial blood gas data from 2269 ventilation episodes. Early prophylactic hyperventilation, i.e., hypocapnia in the first 24 hrs, was used in 54% of episodes (10) (Fig. 2) . Furthermore, the majority of patients who did not have increased ICP had significant hypocapnia for up to 50% of their total ventilation time. More than 90% of patients with Paco 2 Յ30 mm Hg received no monitoring of brain oxygenation (10). In the United States, 36% of U.S. boardcertified neurosurgeons routinely use prophylactic hyperventilation in patients with severe TBI (13).
Hypocapnia in Children. Hypocapnia remains prominent in the management of brain-injured children (8). Retrospective analysis suggests that hypocapnia occurs in 52% of patients and that the 2003 Pediatric Brain Trauma guidelines (12), which recommend strict limitation of hypocapnia, did not alter this (Fig. 3) . The youngest children (Ͻ2 yrs) had the highest incidence of severe hypocapnia, which is a concern given the vulnerability of the neonatal brain and potential for associated intraventricular hemorrhage (14) (Fig. 4) . Severe hypocapnia was common in children without elevated ICP (8). This is of particular concern because hypocapnia predicted inpatient mortality (odds ratio, 2.8; 95% confidence interval, 1.3-5.9) independent of the severity of brain injury (8) .
Hypocapnia in Early Brain Injury. Hypocapnia occurs in brain-injured patients even before intensive care unit admission. Almost 50% of Michigan emergency physicians routinely use prophylactic hyperventilation in patients with severe TBI (15), and accidental hyperventilation is also common (16). The net result is that severe hypocapnia (end expired CO 2 Ͻ30 mm Hg) is seen in 70% of patients transferred by helicopter to a U.S. urban level I trauma center (17). More recently, Warner et al (18) reported that 16% of intubated TBI patients en route to a level I trauma center had Paco 2 levels Ͻ30 mm Hg, whereas 30% had levels of 30 to 35 mm Hg. Such prehospital hypocapnia is clearly associated with adverse outcome in TBI (16, 19) .
What Happens to Cerebral Blood Flow and Oxygen Requirements in the Injured Brain?
Cerebral Blood Flow. Hypocapnia is often used in brain injury to reduce "luxury perfusion," which is thought to worsen edema, especially in children (20) . Furthermore, because injury impairs vascular control, if hypocapnia-induced vasoconstriction were more pronounced in uninjured vs. injured brain (21), then perfusion might be shunted from normal to vulnerable (injured) brain, a concept termed "inverse steal" (21).
These concepts are now largely discredited. CBF and cerebral oxygen delivery are generally decreased after brain injury (22-28), and regional CBF is often markedly decreased particularly in the first 24 hrs (24 -26). In 31% of patients with TBI (26), CBF is below an "ischemic threshold" in which ischemia and cell death may occur (29). Transcranial Doppler demonstrates low-flow early after TBI in two-thirds of patients (30), a situation associated with poor outcome (24, 31). Such hypoperfusion may be worsened by cerebral vasospasm, further worsening outcome (32). Of particular concern, 80% of patients who die of head injury demonstrate profound ischemic neuronal changes (27) .
Cerebral Oxygen Utilization. Braininjured patients commonly have lower metabolisms and cerebral metabolic requirements for oxygen (CMRO 2 ) (33, 34). The "mitochondrial dysfunction hypothesis" (22, 35) suggests that low CBF is secondary to the reduced CMRO 2 , which is, in turn, caused by mitochondrial failure attributable to injury. If true, then it could be that the injured brain can tolerate lower levels of O 2 supply and that further reducing CBF (e.g., hyperventilation) is possible without causing harm (36). Hypocapnia-induced reduction of CBF may be tolerated after TBI because of this lower metabolic rate and perhaps higher oxygen extraction (22). However, assumptions about global events require caution in heterogenous injury because of focal limitation of oxygen diffusion attributable to endothelial swelling, microvascular collapse, and perivascular edema (37). Finally, lowered jugular venous oxygen extraction (e.g., SjO 2 ) may reflect reduced brain O 2 consumption rather than increased CBF.
How Does Hypocapnia Reduce CBV?
The aim of hypocapnia in acute brain injury is to reduce intracranial volume. However, the effect of hypocapnia on CBV is indirect and is mediated via reductions in CBF (38). Positron emission tomography demonstrates that only 30% of the CBV resides in the arteries (39). Hypocapnia has little effect on cerebral venous tone, and dynamic positron emission tomography confirms that CO 2 -induced changes in CBV are mediated by altered arterial, not capillary or venous, volume (38). Thus, the effect of changing Paco 2 on CBF (i.e., arterial) is proportionally greater than its effect on CBV. Reducing CBF by Ͼ30% with hyperventilation corresponds to a reduction of only 7% in CBV (40). Greater degrees of hypocapnia further reduce CBF but do not reduce CBV or ICP (40).
The effect of CO 2 on CBF depends on the individual patient, baseline blood flow, and the part of the central nervous system in question. In individuals CBF is Figure 1 . Relationship between intracranial volume and intracranial pressure. Because the cranial cavity represents a fixed volume, an increase in the volume of brain tissue, tumor, or hematoma can initially be compensated by displacement of volume from another compartment. Acute hypocapnia can reduce cerebral blood volume, thereby attenuating the increase in intracranial pressure. not homogeneous, and areas with higher CBF have a steeper response to altered CO 2 (41). Overall, there is a 3% change in CBF per 1-mm Hg change in Paco 2 (42-44). In different regions, the principle is maintained such that in the cat, a change in Paco 2 of 1 mm Hg results in a blood flow change of 1.7 mL/100 g/min in the cerebral cortex (baseline flow, 86 mL/100 g/min) but a blood flow change of 0.9 mL/100g/min in the spinal cord (baseline flow, 46 mL/100 g/min) (45). Similar CBF responses occur in rabbits (46) and in humans (41). In contrast, the effect on CBV is far smaller than that on CBF (47). Thus, the capacity for hypocapnia to reduce CBV is limited and is achieved at a disproportionate cost to arterial CBF. Because low CBF is common in the first 24 hrs after TBI, early hypocapnia may be particularly harmful (48).
Mechanism of Cerebral Vasoconstriction. The effects of CO 2 are primarily on the cerebral arteries (38), are pH-mediated rather than CO 2 -mediated (49, 50), and occur via a direct effect on the arteriole smooth muscle (49 -51). The larger arteries are less sensitive and the small pial arterioles are most responsive (52). The endothelium and smooth muscle play central roles. Multiple mechanisms involving nitric oxide, vasoactive prostanoids, potassium channels, and intracellular calcium have been implicated. Endothelial release of nitric oxide in response to alterations in CO 2 tension appears to be key (53). Impaired endothelium lessens nitric oxide release and blunts CO 2 reactivity (54), as does inhibition of nitric oxide synthase (55-57). Other mechanisms are nitric oxideindependent. Endothelial synthesis and release of vasodilator prostanoids may be more important in children than in adults (58, 59). Smooth muscle K ϩ channels (e.g., ATP-sensitive K ϩ ) have also been implicated (60 -62). Ultimately, CO 2 modulates smooth muscle intracellular calcium concentration and sensitivity (63).
How Can Hypocapnia Cause Cerebral Hypoxia?
Reduced Cerebral Oxygen Supply. The most serious concern with hypocapnia in brain injury is cerebral hypoperfusion (37, 40, 64 -72). Hypocapnia may worsen cerebral vasospasm, which in turn can worsen outcome (32) and exacerbate preexisting impairment of CBF (65). Hypocapnia does not appear to produce "inverse steal" (i.e., diverting perfusion to ischemic areas) (73). In fact, injured areas may have increased CO 2 responsiveness, raising the possibility that hypocapnia may aggravate secondary ischemic injury by diverting flow from injured brain (74).
Hypocapnia may reduce cerebral O 2 supply via additional mechanisms. Hypocapnic alkalosis may cause bronchoconstriction and attenuation of hypoxic pulmonary vasoconstriction, resulting in net lowering of PaO 2 (75-77); at any given O 2 tension, the leftward shift of the oxyhemoglobin dissociation curve may reduce O 2 off-loading to tissues (78).
Increased Cerebral Oxygen Demand. Hypocapnia may aggravate brain ischemia by increasing cerebral oxygen demand ( Figure 5 ) because of increased neuronal excitability (79, 80). This contributes to increased cerebral utilization and depletion of glucose (81, 82), and a switch to anaerobic metabolism (65, 83). Hypocapnia increases CMRO 2 in TBI (84) and prolongs seizure activity (80). Such seizure potentiation further heightens O 2 demand and results in production of seizure-associated cytotoxic excitatory amino acids (e.g., N-methyl-D-aspartate) (85), which also may be increased by hypocapnia-induced neuronal dopamine (86) . Finally, alkalosis inhibits the negative feedback whereby low pH reduces ongoing endogenous acid production (e.g., lactate) (87), potentially worsening injury further.
Evidence for Hypocapnia-Induced Brain Ischemia. Concerns regarding hypocapnia and adverse neuronal O 2 supply and demand are supported by multiple findings from clinical and experimental studies. First, in children (88) and adults (84, 89) with TBI, hypocapnia causes regional cerebral ischemia. In adults resuscitated after cardiac arrest, hypocapnia reduces SjO 2 (and increases lactate) (90) . In experimental studies, hypocapnia reduces regional CBF and local cortical tissue PO 2 (91) and reduces cerebral oxyhemoglobin (92, 93) and oxidized cytochrome aa3 (93) while increasing cerebral deoxyhemoglobin (93) . Second, hypocapnia produces ischemic changes in functional magnetic resonance imaging (64) and with electroencephalography (94) . Third, brain lactate production (i.e., anaerobic metabolism) is increased by hyperventilation (95) , which may be more severe earlier in TBI (96) . However, alkalosis may directly stimulate glycolysis (to buffer alkalosis) and further elevate lactate (97) .
Why Is Sustained Hypocapnia Particularly Deleterious?
Progressive Loss of Effect on ICP. Hypocapnia rapidly elevates the pH of both the CSF and the central nervous system extracellular fluid, and the CBF declines correspondingly. Severinghaus et al (98) demonstrated, 4 decades ago, that during prolonged hypocapnia the CSF pH is buffered toward normal and the CBF normalizes. The buffering is a biphasic process. First, there is "tissue buffering" (99, 100), in which hypocapnia immediately lowers the intracellular fluid CO 2 , resulting in exit of Cl Ϫ from intracellular fluid to extracellular fluid and a reciprocal shift of HCO 3 Ϫ from extracellular fluid to intracellular fluid, thereby lowering the extracellular fluid concentration of HCO 3 Ϫ . Second, the renal response-inhibition of H ϩ secretion and HCO 3 Ϫ resorption in the proximal tubule-begins immediately and takes effect over hours to days (99, 100) . Buffering of CSF pH normalizes CBF as quickly as 6 hrs (101), even if the Paco 2 remains low (2). In healthy . An integrated scheme of mechanisms underlying neurologic effects of hypocapnia. Induction of systemic hypocapnia results in a cerebrospinal fluid alkalosis, reducing cerebral blood flow, cerebral oxygen delivery, and, to a lesser extent, cerebral blood volume. This is potentially life-saving in the setting of critically elevated intracranial pressure. However, critical brain ischemia may result, exacerbated by an increase in hemoglobin oxygen affinity and an increase in neuronal excitability. Over time, cerebrospinal fluid pH and, hence, cerebral blood flow gradually return to normal. Normalization of Paco 2 results in cerebral hyperemia and reperfusion injury to previously ischemic brain regions. In addition, hypocapnia may cause glutamate release and neuronal excitotoxicity. Reproduced with permission from Laffey et al (140) .
volunteers, whereas a sustained 20-mm Hg reduction in Paco 2 decreased CBF by 40% immediately, CBF was restored to 90% of normal by 4 hrs (2) .
Rebound Intracranial Hypertension with Restoration of Normocapnia. Rebound elevation in ICP after restoration of normocapnia is well-described. Because HCO 3 Ϫ is the only buffer in extracellular brain fluid, loss of bicarbonate, an obligatory consequence of hypocapnia, greatly reduces its buffering capacity. Therefore, normalization of Paco 2 leads to an overshoot in CSF pH and a corresponding overshoot increase in CBF. Experimental induction of hypocapnia (Paco 2 25 mm Hg, anesthetized rabbit) followed by normocapnia for 10 mins every 4 hrs was associated with progressively less effective hypocapnic vasoconstriction (102) . Temporary restoration of normocapnia every 4 hrs caused vasodilation. At 20 hrs arterial pH had returned to baseline and by 24 hrs the CSF pH was normal. Similar results were reported in the anesthetized goat in which restoration of normocapnia caused marked cerebral hyperemia (103) .
These findings have important implications. First, buffering of CSF pH ablates the effectiveness of ongoing hypocapnia, and CBF may return to baseline levels by 4 hrs. Second, when hypocapnia is continued, it is difficult to further reduce CO 2 to decrease ICP acutely, should this become necessary later (e.g., incipient herniation), without causing lung damage. Third, rebound intracranial hypertension should be anticipated after restoration of normocapnia and could result in brainstem herniation (or, in premature infants, intracranial hemorrhage) (68, 104 -106) (Fig. 5) . This is particularly important in severe hypocapnia because the slope of the relationship between CSF pH vs. CBF is steepest at this level (107) . Thus, if hypocapnia is induced, then it should be brief while definitive measures to control ICP are undertaken, and Paco 2 should be targeted toward normal as soon as possible.
Does Hypocapnia Damage Neurons?
Hypocapnia and Neurotransmission. Hypocapnia mediates increases in neuronal excitability and potentiates seizure activity that may result in local production of seizure-associated excitatory amino acids, including N-methyl-D-aspartate, that are locally cytotoxic (Fig. 5) . Severe hypocapnia increases N-methyl-D-aspartatereceptor-mediated neurotoxicity (85) and increases neuronal dopamine, particularly in the striatum, which may worsen reperfusion injury, especially in the immature brain (86) . Finally, hypocapnia may be directly neurotoxic through increased incorporation of choline into membrane phospholipids (108) .
Cerebral Ischemia and Reperfusion Injury. Hypocapnia may worsen neuronal ischemia and reperfusion injury. Hypocapnia during resuscitation after cardiac arrest is associated with worsened brain injury (109) and it aggravates hypoxicischemic central nervous system damage (110, 111) . These findings are consistent with its potentiation of reperfusion injury in the myocardium (112) and the lung (113) . The central nervous system effects of hypocapnia are particularly prominent in the immature brain (110, 111) .
What Is the Role of Hypocapnia in Specific Neurologic Conditions?
Spontaneous vs. Induced Hypocapnia. Whereas induced hypocapnia is the focus of this article, hypocapnia is often spontaneous. Spontaneous hyperventilation has long been associated with adverse outcome in TBI and subarachnoid hemorrhage (114) and after stroke (115); however, whether the spontaneous hyperventilation reflected severity of the lesion or caused/contributed to it is unclear. More recently, spontaneous and induced hyperventilation have been associated with adverse outcome in trauma, but only induced hyperventilation was independently predictive (116) .
TBI. There is no evidence to suggest that hypocapnia improves outcome in acute brain injury; in fact, prolonged hyperventilation worsens outcome. In a landmark, randomized, clinical trial, patients with TBI were assigned to receive normal ventilation (target Paco 2 , 35 mm Hg) vs. prophylactic hyperventilation (target Paco 2 , 25 mm Hg); the prophylactic hyperventilation resulted in fewer of the less severely injured patients (Glasgow Coma Scale motor score, 4 -5) having a favorable outcome at 3, 6, and 12 months (117) . Beyond the outcome disadvantages, prolonged hypocapnia in these patients increased the overall level and variability of ICP, especially after 60 hrs of hyperventilation, indicating that hypocapnia became ineffective or counterproductive in controlling ICP over time (117) . Neonatal Brain Injury. Hypocapnia is common in neonatal practice. It is injurious to the premature brain and is associated with multiple neonatal brain conditions, including neonatal white matter injury (69, 118 -122) (Fig. 4; Table 2 ). Hypocapnia is often the sole risk factor for periventricular leukomalacia (123), a syndrome associated with significant neonatal mortality and neurodevelopmental deficit, and may be a cause of pontosubicular necrosis, another acute brain injury syndrome of prematurity (120) . Whether hypocapnia contributes to cerebral palsy remains unanswered (124) .
Even brief exposure of preterm infants to severe hypocapnia (Paco 2 Ͻ15 mm Hg) is associated with considerable longterm neurologic abnormalities (14), including sensorineural hearing loss (68). In this setting, predisposing factors may include vulnerable areas with poorly developed vascular supply (125), antioxidant depletion by excitatory amino acids (126) , and the effects of lipopolysaccharide (127) and cytokines (128) in potentiating white matter destruction (Fig. 4) . Outcome data indicate an adverse role of hypocapnia after hyperventilation (14), high-frequency ventilation (129), or extracorporeal membrane oxygenation (68). Finally, abrupt termination of hyperventilation results in reactive hyperemia, which may precipitate intracranial hemorrhage in premature neonates (106) .
Acute Stroke. Hyperventilation has classically been advocated as a therapy in stroke for two reasons. First, hypocapnia was considered to result in shunting of blood to the ischemic brain area by constricting the normally autoregulated brain, the so-called inverse steal phenomenon that is now known not to occur (73). Second, hypocapnia was believed to correct acidosis in areas adjacent to the ischemic zone to minimize the extension of the infarct (21). In fact, hypocapnia is associated with poor prognosis in stroke (115, 130) . Although separating cause vs. effect is difficult (because large strokes are commonly accompanied by spontaneous hyperventilation), the recurrence of a 
Impairment of Neurologic Function. The potential for neurologic dysfunction after (even brief) hypocapnia is most clearly documented in postoperative patients. Healthy patients subjected to hypocapnia have significantly impaired psychomotor function for up to 48 hrs postoperatively, and such effects are more marked and occur with less severe hypocapnia in older patients (132) . More profound intraoperative hypocapnia (Ͻ24 mm Hg), even for a relatively short duration, can delay reaction times for up to 6 days (133) . Hypocapnia may impair attention and learning and can induce personality changes (134, 135) . At severe levels (Paco 2 15 mm Hg), hypocapnia decreases basic psychomotor performance in healthy volunteers (136) . That hypocapnia causes such dysfunction is supported by the finding that exposure to elevated Paco 2 during anesthesia enhances neuropsychologic performance (132, 137) . Reassuringly, the adverse effects of hypocapnia in studies of postoperative cognition in healthy patients, while often prolonged, seem ultimately reversible (132, 133) .
Prolonged exposure to hypocapnia may result in sustained impairment. The neurologic impairment seen in healthy mountaineers at extreme altitude is most closely correlated to the degree of hypocapnia, not the level of hypoxia (138) . The basis for acute central nervous system symptoms at altitude appears to be alkalosis, and such alkalosis can be prevented by pretreatment with acetazolamide (139).
Can Hypocapnia Damage Other Organs?
Hypocapnia can injure other organs, and the effects on the lung and vasculature are well-described (140) . Hypocapnia decreases perfusion to the heart (141), liver, gastrointestinal tract (142), skeletal muscle (143) , and skin (144) . This review focuses on brain injury and, because oxygenation and perfusion are central, this section summarizes the effects of hypocapnia on lung injury and on myocardial oxygenation.
Acute Lung Injury. More than 20% of patients with severe brain injury have acute lung injury or acute respiratory distress syndrome develop (145, 146) , which worsens outcome (147) and is independently predicted by the use of high tidal volume to produce hypocapnia (145), a finding confirmed prospectively in a multicenter European study (145) . Unfortunately, patients with confirmed lung injury continue to be hyperventilated (145) despite the known association between high tidal volume and mortality in acute respiratory distress syndrome (148) .
The concept that hypocapnia might be pathogenic in acute lung injury/acute respiratory distress syndrome was suggested in 1971 by Trimble et al (149) . Hypocapnia may contribute to acute lung injury because high tidal volume ventilation (usually used to achieve hypocapnia) directly causes lung injury (148) , and the hypocapnia per se may injure the lung via several mechanisms (Table 3) , including increased lung permeability and edema (113) , decreased compliance (150), perhaps by surfactant inhibition (151) , and potentiating acute inflammation (152) (153) (154) . Many of these adverse effects can be ameliorated by normalizing alveolar CO 2 (151, 152, 154, 155) and, conversely, hypercapnic acidosis reduces experimental lung injury (154, 156 -159) . Finally, hypocapnia attenuates hypoxic pulmonary vasoconstriction, thereby increasing intrapulmonary shunt (160) . After acute brain injury, it is difficult to discern the individual contributions of high tidal volume vs. hypocapnia to lung injury.
Myocardial Ischemia. Acute hypocapnia lowers myocardial O 2 delivery (161-167) and increases demand (141, 164, 168 -170) through a variety of mechanisms including increased contractility (168, 171) , left ventricular afterload (172) , and heart rate (173), thereby worsening the supply-and-demand balance (164, 167) (Table 4 ). Hypocapnia reduces coronary flow (163) , increases tissue capillary permeability (165) , and may cause frank coronary spasm, resulting in "variant angina" that classically occurs with spontaneous hyperventilation (167) . Finally, hypocapnia may precipitate thrombosis through increased platelet levels or aggregation (174) . Thus, clinically relevant acute coronary phenomena exist in brain-injured patients managed with hypocapnia.
Cardiac Dysrhythmias. Hypocapnia causes dysrhythmias (175) (Table 4) , including paroxysmal atrial arrhythmia (176) and (rarely) ventricular tachycardia (177) or fibrillation (178) . Aside from potentiating myocardial ischemia, the mechanisms are unclear. However, hypocapnic alkalosis may be an effective therapy for toxicity attributable to local anesthetic (179) or tricyclic antidepressant (180) .
Can We Use Hypocapnia to Produce Benefit While Minimizing Harm?
Whether hypocapnia can be used to produce benefit while minimizing harm is a key question. Hyperventilation is the most effective means for acutely lowering ICP (181) . The deleterious effects of hypocapnia in the injured brain stem, at least in part, form limitations regarding how we use hypocapnia in brain-injured patients. Therefore, monitoring of indices of cerebral cellular oxygenation might enhance the safety of using more moderate levels of hypocapnia for shorter periods to control ICP.
Safety of Moderate Hypocapnia. The more severe the hypocapnia and the greater (176) (177) (178) the duration of its use, the greater the potential there is for harm. This potential for harm is reduced when mild-to-moderate hypocapnia is used for limited periods of time. Brief moderate hyperventilation may transiently restore autoregulation of CBF in head-injured patients (182, 183) . Autoregulation of CBF protects the brain from excessive shifts in CBF attributable to alterations in systemic blood pressure and is impaired in 50% to 90% of patients with severe TBI (184, 185) . One study demonstrated that moderate hypocapnia (PCO 2 28 mm Hg) temporarily improved cerebral autoregulation in head-injured patients (182) . Conversely, more severe hypocapnia (PCO 2 23 mm Hg) impaired autoregulation (182) . In addition, the effect of hypocapnia on autoregulation of CBF with hypocapnia is quite variable (183) and the duration of any beneficial effect is unclear, but it may be short-lived (182) . Furthermore, any beneficial effects of hypocapnia on autoregulation must be set against the potential for hypocapniainduced cerebral ischemia. The potential for brief "moderate" hypocapnia to cause ischemia is clear from the finding that 20 mins of moderate hypocapnia (Paco 2 27-32 mm Hg) can produce critical reductions in regional brain tissue PO 2 in 20% of patients with TBI (23). Thus, the idea of a safe "threshold" level of hypocapnia is not an idea that can be generalized to populations of brain-injured patients.
Titrated Hypocapnia: A Feasible Strategy? Several investigators have raised the potential that hypocapnia might safely be titrated, in individual patients, against indices of cerebral oxygenation. It has been proposed that 20% of TBI patients with intracranial hypertension may have CBF in excess of that needed for metabolism on the basis of SjO 2 measurements (186, 187) . In such patients, "optimized hyperventilation" has been proposed in which hypocapnia (lowering ICP) is titrated against SjO2 (to monitor global O 2 supply-and-demand balance) (186, 187) . However, global indices of oxygenation are insensitive to regional imbalances. Placement of regional monitors of brain oxygenation near the penumbra of focal lesions clearly demonstrates the limitations of global indices of cerebral oxygenation (188) . Titrating hyperventilation to CMRO 2 has also been proposed on the basis that brief (10 mins) episodes of severe hypocapnia did not reduce global or regional CMRO 2 , even in areas of the brain where CBF was low (22). However, baseline CMRO 2 was very low in areas of poor cerebral perfusion, and hypocapnia did greatly increased oxygen extraction ratio in the venous blood from these areas (22). Nevertheless, these data suggested that O 2 supply to these tissues was adequate and that hypocapnia could be used safely (22).
In contrast, other positron emission tomography studies indicate that moderate hypocapnia (Paco 2 30 mm Hg) may cause focal brain ischemia (89) based on the calculation of a critical oxygen extraction fraction for each subject and estimation of the volume of brain tissue with oxygen extraction fraction values below this threshold as determined by positron emission tomography scanning. Using this approach, hypoventilation elevates CPP and lowers ICP, but the volume of severely hypoperfused tissue within the injured brain is raised (89) . This group further demonstrated that the injured brain is less able to increase O 2 extraction in response to reduced O 2 delivery (37), phenomena not detectable using routine central nervous system monitors (including SjO 2 ) (84). Most worrisome is the more recent observation that in TBI, hypocapnia may increase focal brain CMRO 2 associated with increased cortical electrical activity (84).
An overriding concern is that because hypocapnia can directly modulate CMRO 2 (84), it may invalidate the use of CMRO 2 to define thresholds for cerebral ischemia. This may explain why hypocapnia did not reduce CMRO 2 despite large reductions in CBF and increases in oxygen extraction ratio (22).
It is increasingly clear that there is significant heterogeneity in regional oxygenation in the injured brain. Substantial intercompartmental pressure differentials can exist in the injured brain (189 -191) and these, rather than globally increased ICP, may be the proximate cause of herniation syndromes (190, 191) . Finally, because vasoresponsiveness to CO 2 may be increased (up to threefold) after TBI (74), hypocapnia could exacerbate intercompartmental pressure differentials, increasing the risk of local herniation.
Regional Cerebral Monitoring: The Future? There is no safe "threshold" level of hypocapnia that can be used in all brain-injured patients. Furthermore, the presence of significant regional heterogeneity in TBI renders global indices of cerebral perfusion or oxygenation inadequate. An alternative approach may be the use of brief episodes of moderate hypocapnia titrated against regional indices of cerebral oxygen and against intercompartmental pressure gradients. Technological advances such as regional brain tissue PO 2 monitoring, bedside imaging, and microdialysis, as well as regional ICP monitoring, may together enhance outcome. In this paradigm, the ultimate clinical utility of hypocapnia in acute brain injury will depend on its potential to cause direct harm in the injured brain.
What Is the Current Role for Hypocapnia in Acute Brain Injury?
Imminent Brain Herniation. There is a strong physiologic (and empirical) rationale for brief use of hypocapnia to acutely reduce ICP. Although the evidence is limited, the rapidity of induction and its immediate effect on CBF make it a useful strategy while definitive measures are being instituted.
Intraoperative Use During Neurosurgery. Hypocapnia is used during neurosurgery to facilitate access or to acutely reduce brain bulk (192) . This was successfully demonstrated in a prospective, randomized, crossover study in patients with supratentorial brain tumors (193) in which brief (20 mins) intraoperative hyperventilation reduced brain bulk and reduced ICP, although the longer-term effects were not reported.
It is important to remember that when acute hypocapnia is used in these settings, normocapnia should be restored as soon as is feasible, because hypocapnia becomes ineffective within hours. This means that hypocapnia can be used later to control further worsening of ICP and it avoids the risk of rebound hyperemia with delayed CO 2 normalization.
CONCLUSIONS
Hypocapnia, often prolonged, remains prevalent in the management of brain injury. Despite this, there is no proof (other than experience with incipient herniation) that hypocapnia improves neurologic outcome in any context. On the contrary, hypocapnia can certainly cause or worsen cerebral ischemia, worsen outcome, and cause (direct or indirect) injury to other organs. The decision to institute hypocapnia for therapeutic purposes in the setting of acute brain injury should be undertaken only after careful consideration of the risks and benefits. Accidental hypocapnia should always be avoided, and prophylactic use has no clinical role. The use of hypocapnia might be best limited to the emergency management of life-threatening ICP or to acutely reduce brain bulk in the operating room, pending institution of definitive measures. In these settings, normocapnia should be re-instituted as soon as is feasible. Contrary to suggestions that prospective trials of prophylactic hyperventilation in head injury are needed (194) , we believe, based on the data presented, that such studies are difficult to justify at this stage given the increasing recognition that this approach is frequently harmful and rarely, if ever, beneficial. Lippincott 
